What's new

[Cyprus Times] Kyriakidou on monkey smallpox: "The new intradermal vaccination strategy is extremely important"

epitropos-kyriakidou-stella.jpg
[/ATTACH]
EMA recommendations for intradermal doses for monkey smallpox can quintuple vaccinations "Extremely important new intradermal vaccination strategy" says Commissioner Kyriakidou

A new smallpox vaccination strategy against monkeypox[/B] with a smaller dose and intradermal injection is recommended by the European Medicines Agency's Emergency Task Force (ETF), with the aim that the currently limited supplies of the vaccine can be used to vaccinate as many people as possible.

"Today's recommendation by the European Medicines Agency for a new intradermal vaccination strategy for monkeypox is extremely important as it allows five times more people to be vaccinated with the doses we have available," commented Health Commissioner Stella Kyriakidou.

In particular, the EMA's team of experts reviewed the data regarding the administration of the Imvanex monkeypox vaccine by intradermal injection (i.e. just under the upper layer of the skin).

The vaccine has so far only been approved for subcutaneous injection (injection under the skin). However, according to experts, a lower dose of the vaccine can be used for intradermal administration.

Based on the data reviewed by experts, national authorities may, as a temporary measure while stocks of the vaccine remain low, administer Imvanex as an intradermal injection at a lower dose to protect people at risk of monkeypox infection.

The Emergency Task Force (ETF) reviewed data from a clinical trial involving approximately 500 adults, comparing the effectiveness of administering the vaccine either intradermally or subcutaneously as 2 doses with a 4-week interval between each dose.

Subjects who received the vaccine intradermally received one-fifth (0.1 ml) of the subcutaneous dose (0.5 ml), but produced similar levels of antibodies to those who received the higher subcutaneous dose, it noted.



Experts cautioned that a greater risk of local reactions (e.g., longer-lasting redness and thickening or discoloration of the skin) was found after intradermal injections.

Source: CNA


Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times

Source
 
Back
Top